TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive In Brief: Griesemer Returns To NIEHS to Head Toxicology Research & Testing; Robert Burnight Dies at 69 August 12, 1988
TCL Archive CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell November 12, 1976